Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other T-Cell Based Immunotherapies, such as
Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: "SCPS"), a biotechnology company developing transformational therapeutics for serious diseases with significant unmet medical need, and its
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on Novem
Scopus BioPharma (NASDAQ:SCPS) Shares Down 8.3%
Shares of Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) dropped 8.3% on Wednesday . The company traded as low as $0.10 and last traded at $0.11. Approximately 21,957 shares traded hands during mid
Scopus BioPharma Inc. (NASDAQ:SCPS) Sees Significant Increase in Short Interest
Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 60,400 share
12 Health Care Stocks Moving In Friday's Intraday Session
GainersImmuron (NASDAQ:IMRN) shares increased by 37.9% to $2.22 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 17.1 million shares, making up 288523.4% of it
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersIsoPlexis (NASDAQ:ISO) stock moved upwards by 131.1% to $1.59 during Thursday's regular session. Trading volume for IsoPlexis's stock is 33.5 million as of 12:30 EST. This is 80056.9% of its av
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersAthenex (NASDAQ:ATNX) stock moved upwards by 41.4% to $0.19 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 112.5 million, which is 9232.0% of its average
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.Axcella Heal
Stocks That Hit 52-Week Lows On Monday
 On Monday, 297 companies reached new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Airbnb (NASDAQ:ABNB).The smallest com
12 Health Care Stocks Moving In Monday's Intraday Session
GainersMadrigal Pharmaceuticals (NASDAQ:MDGL) stock rose 232.5% to $212.11 during Monday's regular session. Trading volume for Madrigal Pharmaceuticals's stock is 6.6 million as of 12:30 EST. This is
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.Maxar Technologies Inc. (NYSE:MAXR) shares jumped 120.2%
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersExact Sciences (NASDAQ:EXAS) shares increased by 17.9% to $52.6 during Friday's pre-market session. The company's market cap stands at $9.3 billion. IMAC Holdings (NASDAQ:BACK) shares increased
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
Gainers Minim, Inc. (NASDAQ:MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.Lanvin Group (NASDAQ:LA
Short Interest in Scopus BioPharma Inc. (NASDAQ:SCPS) Decreases By 38.0%
Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) was the recipient of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 23,800 shares, a d
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersExact Sciences (NASDAQ:EXAS) shares rose 23.3% to $54.99 during Thursday's after-market session. This security traded at a volume of 384.9K shares come close, making up 18.1% of its average vol
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ:CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.Core Scientific, Inc. (
Federal Reserve's Still-Hawkish Stance Appears to Disappoint Investors; US Futures Move Lower
08:16 AM EST, 12/15/2022 (MT Newswires) -- Despite the Federal Reserve only raising rates by half a percentage point following four consecutive 75 basis point rate hikes, investors appeared disappoint
Top Premarket Gainers
07:42 AM EST, 12/15/2022 (MT Newswires) -- Scopus BioPharma (SCPS) shares surged 111% premarket on Thursday, after falling 4.2% on Wednesday. Core Scientific (CORZ) shares rallied 53%, adding to a 70%
No Data